Photodynamic therapy is witnessing a revival of its origins as a response to the rise of multi-
drug resistant infections and the shortage of new classes of antibiotics. Photodynamic …

Antimicrobial resistance is threatening to overshadow last century's medical advances.
Etiological agents of previously eradicated infectious diseases are now resurgent as …

Photodynamic therapy (PDT) was initially discovered over 100 years ago by its ability to kill
microorganisms, but its use to treat infections clinically has not been much developed …

Microbial infection is a severe concern, requiring the use of significant amounts of
antimicrobials/biocides, not only in the hospital setting, but also in other environments. The …

Antimicrobial photodynamic therapy (PDT) or photodynamic inactivation (PDI) is a new
promising strategy to eradicate pathogenic microorganisms such as Gram-positive and …

Abstract The Infectious Diseases Society of America (IDSA) highlights that over the past
several years, the number of new antibacterial drugs approved continues to decrease …

The advent of antimicrobial resistance has added considerable impact to infectious diseases
both in the number of infections and healthcare costs. Furthermore, the relentless …

The story of prevention and control of infectious diseases remains open and a series of
highly virulent pathogens are emerging both in and beyond the hospital setting. Antibiotics …

According to a 2019 report from the Center for Disease Control and Prevention (CDC), more
than 2.8 million antibiotic-resistant infections occur in the US each year, and more than …

Photodynamic therapy (PDT) employs a non-toxic dye, termed a photosensitizer (PS), and
low intensity visible light which, in the presence of oxygen, combine to produce cytotoxic …